The Kv1.3 blocker PAP‑1 alleviates psoriasis‑like dermatitis in rats via suppressing inflammation and angiogenesis
Open Access
- 20 July 2026
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Abstract
Psoriasis is a chronic inflammatory skin disorder driven by epidermal hyperplasia, immune infiltration, and pathological angiogenesis. PAP‑1, a selective Kv1.3 channel blocker, exhibits therapeutic potential, though its underlying mechanisms remain incompletely understood. Here, we show that both preventive and therapeutic administration of PAP‑1 markedly attenuates imiquimod (IMQ)-induced psoriasis‑like skin lesions and reduces splenomegaly in male rats. RNA sequencing revealed that PAP-1 downregulated genes associated with inflammation and angiogenesis, accompanied by decreased levels of pro-inflammatory cytokines and vascular markers. PAP-1 also inhibited VEGF-A-induced HUVEC proliferation, migration, invasion, and tube formation. Mechanistically, PAP-1 not only blocked Kv1.3 currents, but also suppressed Kv1.3 expression in the skin of IMQ-induced psoriasis-like male rats and VEGF-A-induced HUVECs. Cryo-EM structural analysis revealed that PAP-1 binds within the central cavity of Kv1.3, beneath the selectivity filter, in an inactivated state. These results establish that preventive and therapeutic PAP-1 alleviates psoriasis-like dermatitis via dual anti-inflammatory and anti-angiogenic mechanisms, supporting its further therapeutic development.Keywords
Funding Information
- National Natural Science Foundation of China (82371575)
- National Natural Science Foundation of China (82304505)
- Anhui Province Excellent Research and Innovation Team Project
This publication has 44 references indexed in Scilit:
- Diosmin nanocrystal gel alleviates imiquimod-induced psoriasis in rats via modulating TLR7,8/NF-κB/micro RNA-31, AKT/mTOR/P70S6K milieu, and Tregs/Th17 balanceInflammopharmacology, 2023
- Assessment of Life Quality, Stress and Physical Activity Among Patients with PsoriasisDermatology and Therapy, 2021
- Discovery of KV1.3 ion channel inhibitors: Medicinal chemistry approaches and challengesMedicinal Research Reviews, 2021
- Soluble IL-6R-mediated IL-6 trans-signaling activation contributes to the pathological development of psoriasisJournal of Molecular Medicine, 2021
- An effective method of isolating microvascular endothelial cells from the human dermisCell Biology International, 2020
- Proinflammatory and anti-inflammatory cytokine profiles in psoriasis: use as laboratory biomarkers and disease predictorsInflammation Research, 2019
- The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis PathogenesisClinical Reviews in Allergy & Immunology, 2018
- K+ Channels Expression in Hypertension After Arterial Injury, and Effect of Selective Kv1.3 Blockade with PAP-1 on Intimal Hyperplasia FormationCardiovascular Drugs and Therapy, 2014
- CHARMM-GUIMembrane Buildertoward realistic biological membrane simulationsJournal of Computational Chemistry, 2014
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009